Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 2,826-2,850 of 3,186
CompletedNCT04016779

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

This study exists to understand whether the medication SPN-812 is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication SPN-812 can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
CompletedNCT04398225

A Trial to Assess the Pharmacokinetics, Safety, and Tolerability of Centanafadine in Pediatric Subjects With Attention-deficit/Hyperactivity Disorder

This study exists to better understand the safety of this type of care and how manageable it feels in practice. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

ADHDOtherFrom 4 Years to 12 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
CompletedNCT02829970

Helping College Students With ADHD Lead Healthier Lifestyles

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 24 Years
Countries
United States
Sponsor
University of Maryland, College Park
Condition
ADHD
CompletedNCT03690674

Lifestyle Enhancement for ADHD Program

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 5 Years to 10 Years
Countries
United States
Sponsor
Seattle Children's Hospital
Condition
ADHD
CompletedNCT03393390

Study of Cognition and Control in Youths

This study exists to compare options and see whether the medication Cognition offers something meaningfully different. Researchers are trying to understand whether the medication Cognition can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 18 Years
Countries
United States
Sponsor
University of Michigan
Condition
ADHD
TerminatedNCT03242772

Impact of Combined Medication and Behavioral Treatment for ASD & ADHD

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 36 Months to 131 Months
Countries
United States
Sponsor
Duke University
Condition
ADHD
CompletedNCT04386096

Web Based Tools to Improve Medication Continuity in Adolescents With ADHD

This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 11 Years to 15 Years
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Condition
ADHD
CompletedNCT01883817

Effect of Omega-3 Fatty Acid on Cortical Function in ADHD

This study exists to explore whether brain scans or other body measurements could improve care and understanding. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 5 Years to 15 Years
Countries
United States
Sponsor
University of Cincinnati
Condition
ADHD
CompletedNCT03605680

A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
CompletedNCT00500071

Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 12 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
CompletedNCT03628781

Improving ADHD Behavioral Care

This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 5 Years to 12 Years
Countries
United States
Sponsor
Children's Hospital Medical Center, Cincinnati
Condition
ADHD
CompletedNCT00486551

Anger Control Training for Youth With Tourette Syndrome

This study exists to compare options and see whether acceptance and commitment therapy, a talking treatment, offers something meaningfully different. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 11 Years to 16 Years
Countries
United States
Sponsor
Yale University
Condition
ADHD
CompletedNCT04647903

Study to Evaluate the Abuse Liability, Pharmacokinetics, Safety and Tolerability of an Abuse-Deterrent d-Amphetamine Sulfate Immediate Release Formulation (ADAIR)

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

ADHDOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Vallon Pharmaceuticals, Inc.
Condition
ADHD
CompletedNCT01907360

Pharmacokinetics of HLD200 in Children and Adolescents With ADHD

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.

ADHDOtherFrom 6 Years to 17 Years
Countries
United States
Sponsor
Ironshore Pharmaceuticals and Development, Inc
Condition
ADHD
TerminatedNCT03523663

System for Determining Ideal Drug Doses for ADHD - Stages 1 and 2

This study exists to see whether symptom tracking and monitoring can make care clearer and more responsive. Researchers are trying to understand whether symptom tracking and monitoring can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 8 Years to 12 Years
Countries
United States
Sponsor
University of Wisconsin, Madison
Condition
ADHD
CompletedNCT04018794

Development of a Mobile App for an Executive Functioning Intervention for Adolescents

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 11 Years to 15 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
ADHD
CompletedNCT02635035

Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can better support energy, concentration, and everyday functioning.

ADHDOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
ADHD
CompletedNCT02547428

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether the medication Centanafadine offers something meaningfully different. Researchers are trying to understand how people respond to the medication Centanafadine in practice and what may need to be adjusted.

ADHDOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
CompletedNCT04648553

Task-Based Grounding Program

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.

ADHDOtherOver 9 Years
Countries
United States
Sponsor
Dartmouth-Hitchcock Medical Center
Condition
ADHD
United States | Clinical Trials | HopeStage Research